LL-37

LL-37 is a synthetic antimicrobial peptide derived from the human cathelicidin protein (hCAP-18), studied in controlled laboratory environments for its interaction with innate immune signaling pathways and membrane-active mechanisms. As a cationic host defense peptide, LL-37 has been investigated for its role in microbial membrane disruption research, immunomodulatory signaling models, and inflammatory pathway regulation frameworks. Due to its broad-spectrum biological activity profile, it remains a compound of interest in immunology and cellular defense research.

Preclinical investigations have examined LL-37 for its influence on chemotactic signaling pathways, cytokine modulation research, and epithelial barrier function models. Ongoing scientific studies continue to evaluate its receptor-independent membrane interactions, intracellular immune signaling cascades, and antimicrobial mechanism dynamics within strictly controlled experimental settings.

This research peptide is supplied in a 3ML vial and manufactured under strict laboratory-controlled standards. Each batch undergoes analytical verification to confirm molecular identity, purity, and structural integrity. LL-37 is intended strictly for laboratory research and analytical purposes only and is not for human consumption.